Keppra kan desuden bruges som tillægsbehandling til patienter, der i forvejen får et andet lægemiddel mod epilepsi, til behandling af: • partielle anfald med eller uden generalisering hos patienter over 4 år • myoklone anfald (kortvarige, rykvise trækninger i en muskel eller muskelgruppe) hos patienter over 12 år med juvenil myoklon epilepsi • primære generaliserede tonisk- kloniske anfald (større anfald med tab af bevidsthed) hos patienter over 12 år med idiopatisk generaliseret epilepsi (dvs. en form for epilepsi, der menes at være genetisk betinget).
Keppra can also be used as adjunctive therapy in patients who already receive other anti-epileptic medicines to treat: • partial onset seizures with or without generalisation in patients from four years of age, • myoclonic seizures (short, shock-like jerks of a muscle or group of muscles) in patients from 12 years of age with juvenile myoclonic epilepsy, • primary generalised tonic-clonic seizures (major fits, including loss of consciousness) in patients from 12 years of age with idiopathic generalised epilepsy (the type of epilepsy that is thought to have a genetic cause).